Revenio Group Corporation (REG1V) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Revenio Group Corporation (REG1V) has a cash flow conversion efficiency ratio of -0.029x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.40 Million ≈ $-3.97 Million USD) by net assets (€117.30 Million ≈ $137.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see REG1V market cap overview for the company's overall valuation and market capitalisation.
Revenio Group Corporation - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Revenio Group Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Revenio Group Corporation for real-time trading data and today's change.
Revenio Group Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Revenio Group Corporation ranked by their cash flow conversion efficiency. Review cash generation quality of Revenio Group Corporation to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Seah Holdings
KO:058650
|
0.007x |
|
Fujian Superpipe
SHE:300198
|
0.019x |
|
Soyea Technology Co Ltd
SHE:000909
|
0.036x |
|
Beijing Airport High-Tech Park Co Ltd
SHG:600463
|
0.008x |
|
Bintang Oto Global Tbk PT
JK:BOGA
|
0.031x |
|
Guangzhou Shangpin Home Collection Co Ltd
SHE:300616
|
0.018x |
|
Panoro Minerals Ltd.
V:PML
|
-0.044x |
|
HELLOFRESH UNSP.ADS/025
F:HFG0
|
0.203x |
Annual Cash Flow Conversion Efficiency for Revenio Group Corporation (2001–2025)
The table below shows the annual cash flow conversion efficiency of Revenio Group Corporation from 2001 to 2025. Also see REG1V total asset value for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €114.70 Million ≈ $134.10 Million |
€30.20 Million ≈ $35.31 Million |
0.263x | +18.79% |
| 2024-12-31 | €107.71 Million ≈ $125.92 Million |
€23.87 Million ≈ $27.91 Million |
0.222x | +103.85% |
| 2023-12-31 | €99.89 Million ≈ $116.79 Million |
€10.86 Million ≈ $12.70 Million |
0.109x | -57.46% |
| 2022-12-31 | €90.92 Million ≈ $106.29 Million |
€23.24 Million ≈ $27.17 Million |
0.256x | -6.79% |
| 2021-12-31 | €78.43 Million ≈ $91.69 Million |
€21.51 Million ≈ $25.15 Million |
0.274x | +25.52% |
| 2020-12-31 | €69.71 Million ≈ $81.50 Million |
€15.23 Million ≈ $17.81 Million |
0.218x | +12.60% |
| 2019-12-31 | €64.36 Million ≈ $75.25 Million |
€12.49 Million ≈ $14.60 Million |
0.194x | -66.34% |
| 2018-12-31 | €18.07 Million ≈ $21.13 Million |
€10.42 Million ≈ $12.18 Million |
0.576x | +17.09% |
| 2017-12-31 | €15.99 Million ≈ $18.69 Million |
€7.87 Million ≈ $9.20 Million |
0.492x | +21.86% |
| 2016-12-31 | €14.97 Million ≈ $17.50 Million |
€6.05 Million ≈ $7.07 Million |
0.404x | -10.85% |
| 2015-12-31 | €15.03 Million ≈ $17.58 Million |
€6.81 Million ≈ $7.96 Million |
0.453x | +97.77% |
| 2014-12-31 | €12.06 Million ≈ $14.10 Million |
€2.76 Million ≈ $3.23 Million |
0.229x | -37.51% |
| 2013-12-31 | €14.96 Million ≈ $17.49 Million |
€5.48 Million ≈ $6.41 Million |
0.367x | +595.09% |
| 2012-12-31 | €14.68 Million ≈ $17.16 Million |
€774.00K ≈ $904.89K |
0.053x | -79.51% |
| 2011-12-31 | €16.43 Million ≈ $19.20 Million |
€4.23 Million ≈ $4.94 Million |
0.257x | +193.03% |
| 2010-12-31 | €14.50 Million ≈ $16.95 Million |
€1.27 Million ≈ $1.49 Million |
0.088x | -29.30% |
| 2009-12-31 | €15.74 Million ≈ $18.40 Million |
€1.96 Million ≈ $2.29 Million |
0.124x | -33.34% |
| 2008-12-31 | €17.59 Million ≈ $20.56 Million |
€3.28 Million ≈ $3.83 Million |
0.186x | +25.09% |
| 2007-12-31 | €22.22 Million ≈ $25.98 Million |
€3.31 Million ≈ $3.87 Million |
0.149x | +163.43% |
| 2006-12-31 | €10.96 Million ≈ $12.81 Million |
€620.00K ≈ $724.85K |
0.057x | -71.65% |
| 2005-12-31 | €5.02 Million ≈ $5.87 Million |
€1.00 Million ≈ $1.17 Million |
0.200x | +332.85% |
| 2004-12-31 | €2.16 Million ≈ $2.52 Million |
€-184.78K ≈ $-216.03K |
-0.086x | +84.26% |
| 2003-12-31 | €1.10 Million ≈ $1.29 Million |
€-600.19K ≈ $-701.68K |
-0.545x | +39.72% |
| 2002-12-31 | €4.32 Million ≈ $5.05 Million |
€-3.90 Million ≈ $-4.56 Million |
-0.903x | -4584.91% |
| 2001-09-30 | €17.72 Million ≈ $20.72 Million |
€357.00K ≈ $417.37K |
0.020x | -- |
About Revenio Group Corporation
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Sensors that are accessories of iCare tonometer for measuring intraocular pr… Read more